Evaluation of role of add on probiotics on impact of lung function and bronchial asthma control - A randomized control trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 84
- Locations
- 1
- Primary Endpoint
- To evaluate the role of add on probiotics on impact of lung function by spirometry and bronchial asthma control
Study Overview
Brief Summary
This study is a randomized parallel group trial to evaluate the role of add on probiotics (lactobacillus fermentum 4 billion cells once daily for 2 months) on impact of lung function and bronchial asthma control that will be conducted in Chettinad Hospital and Research Institute, Kelambakkam,Tamil Nadu, India.The primary outcome is to evaluate the role of add on probiotics on impact of lung function by spirometry and bronchial asthma control.The secondary outcome is to study the impact of probiotics supplementation in risk of asthma exacerbation,allergic rhinitis and its impact on asthma scoring for a period of 2 months.
Study Design
- Study Type
- Interventional
- Allocation
- Random Number Table
- Masking
- Open Label
Eligibility Criteria
- Ages
- 18.00 Year(s) to 65.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •All adult stable asthma with or without atopy and allergic rhinitis Both genders.
Exclusion Criteria
- •Acute Respiratory infection including Tuberculosis Exacerbation Subjects contraindicated and unable to perform spirometry Underlying respiratory disorders.
Outcomes
Primary Outcomes
To evaluate the role of add on probiotics on impact of lung function by spirometry and bronchial asthma control
Time Frame: Baseline,4 weeks,8 weeks and 12 weeks
Secondary Outcomes
- To study the impact of probiotics supplementation in risk of asthma exacerbation allergic rhinitis and its impact on asthma scoring(3 months)